Bullous pemphigoid
Also known as: BP, autoimmune subepidermal blistering disease, bullous pemphigoid disorder
Bullous pemphigoid is an autoimmune subepidermal blistering disorder, predominantly affecting older adults, presenting with pruritus and tense blisters. Dermatological assessment may include skin histology, perilesional direct immunofluorescence, and pemphigoid antibody testing. Treatment and monitoring remain dermatologist-led; complementary care must not delay diagnosis or replace prescribed therapy. the cited evidence comprises two clinical case reports, a correspondence record without an abstract, and mechanistic research. None evaluates acupuncture or Chinese herbal treatment for bullous pemphigoid, and laboratory findings do not establish patient benefit. Traditional Chinese Medicine (TCM) patterns below are traditional assessment frameworks only, potentially informing supportive symptom discussions after medical stabilisation, not validated disease subtypes or evidence-based treatments for blister prevention.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Utilise loose, non-abrasive apparel to minimise mechanical friction against fragile integument; refrain from intentional rupture of bullae.
- •Adhere strictly to dermatologist-prescribed cleansing and dressing protocols; avoid application of fragranced or irritant topical agents to inflammatory lesions.
- •Maintain regular meals and suitable fluid intake within any cardiovascular or renal restrictions; report weight loss or reduced intake.
- •Keep a daily record of new blisters, itch severity, sleep disruption, and treatment changes to share at clinical review.
Cautions & Contraindications
- •Do not delay biopsy, direct immunofluorescence or specialist review while trying acupuncture or herbs. The diagnostic importance of these investigations is illustrated by the supplied case report.[]
- •Do not stop, taper or substitute prescribed corticosteroids or targeted treatment on the basis of a TCM pattern or symptomatic improvement. The supplied targeted-treatment report is a single case, not evidence for independent treatment changes.[]
- •As a conservative procedural precaution, never needle through bullae, erosions, infected skin or dressings; defer elective needling during widespread active disease or systemic illness. The supplied reports describe the disease context but do not study acupuncture safety.[,]
When to reassess or seek care again
If medically stable and supportive care is agreed, review within 7–14 days using daily new-blister count, itch score from 0–10, sleep disruption, intake, weight where relevant and adverse effects. Dermatology may track BPDAI; its use in the supplied case does not validate TCM treatment. Increasing blisters, worsening erosions or suspected infection require earlier medical review, not completion of an adjunctive trial. Stop adjuncts for adverse reactions or absent meaningful supportive benefit after 2–4 weeks.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Clinical, cosmetic and investigational dermatology · 2026
- The British journal of dermatology · 2026
- Frontiers in immunology · 2026
- Experimental dermatology · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
